← Back to Search

Device

Biophoton Therapy for Stroke

N/A

Recruiting

Research Sponsored by First Institute of All Medicines

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 0-2 weeks, 0-4 weeks after starting the study treatment.

Awards & highlights

Study Summary

This trial will investigate if daily use of Testa BioHealing® Biophoton Generators can help stroke survivors regain independence. 46 adults with chronic stroke will be observed in a live-in center for the study. #ClinicalTrial #Stroke

Who is the study for?

This trial is for adults who had a stroke at least 6 months ago and now need help to live independently. They must have a caregiver, be able to give consent (with assistance if needed), speak English or have translation, not use ventilators, and not have severe illnesses that could affect the study.Check my eligibility

What is being tested?

The trial tests if Testa BioHealing® Biophoton Generators can help chronic stroke patients regain independence by energizing the brain and body. It's randomized and triple-blinded, meaning neither researchers nor participants know who gets real treatment or placebo.See study design

What are the potential side effects?

Since this is an observational study of a non-invasive intervention with biophoton generators, specific side effects are not listed but may include discomfort or skin issues where the device is used.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 0-2 weeks, 0-4 weeks after starting the study treatment.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~0-2 weeks, 0-4 weeks after starting the study treatment.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-2 weeks, 0-4 weeks after starting the study treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Regain Life Independence by Normalizing Activities of Daily Living (ADL).

Secondary outcome measures

Brain injury status detected with EEG (electroencephalogram).

Life Quality Improvement Measured with a Standard SF-36 Questionnaire

Neurologic Examination Using a Standard Neurologic Exam Form to Measure Neurologic Function

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Treatment GroupExperimental Treatment1 Intervention

Active Biophoton Generators are placed under the hotel bed.

Group II: Control GroupPlacebo Group1 Intervention

Placebo-products are placed under the hotel bed.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

First Institute of All MedicinesLead Sponsor

2 Previous Clinical Trials

126 Total Patients Enrolled

1 Trials studying Stroke

46 Patients Enrolled for Stroke

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age limit for participation in this trial over 65 years old?

"Eligibility for this medical trial requires an individual to be at least 18 years old and below the age of eighty."

Answered by AI

Are there any vacancies remaining to join this research endeavor?

"Per the latest data available on clinicaltrials.gov, this research project is currently recruiting patients. It was initially posted in March 31st 2023 and updated most recently on September 16th of the same year."

Answered by AI

Is there an opportunity for me to join this research initiative?

"In order to be eligible for this trial, applicants must have suffered a stroke and fall within the age range of 18-80 years old. The researchers are expecting to recruit 46 individuals altogether."

Answered by AI

What is the upper limit for individuals participating in this clinical experiment?

"Affirmative. According to the information listed on clinicaltrials.gov, this medical trial is currently in search of eligible participants. It was initially posted on March 31st 2023 and its latest update came out September 16th 2023. The research requires 46 patients from a single site for enrollment purposes."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators

2023. "Can Patients With Chronic Stroke Regain Living Independence by Daily Energizing With Biophoton Generators". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06049849.